Genetic Testing Company Invitae Now Contacting Physicians about Possible False Negative Test Results That It Reported in Recent Months

Aug 25, 2017 | Laboratory Management and Operations, Laboratory News, Laboratory Pathology, Laboratory Testing

In recent weeks, company representatives began informing physicians at cancer centers and hospitals about a problem with a specific variant in the MSH2 gene Invitae Corporation (NYSE:NVTA), a genetic testing company in San Francisco, has told some physicians and clinicians in recent weeks that it has reported false-negative results. Clinical laboratory professionals with knowledge of the facts in this case believe the cause of the false negative results may have gone undetected for months and...
;